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Analysis of intracellular enzyme activity by surface
enhanced Raman scattering†
Ross Stevenson,a Sarah McAughtrie,a Laura Senior,a Robert J. Stokes,a
Helen McGachy,b Laurence Tetley,c Paola Nativo,a James M. Brewer,c
James Alexander,b Karen Fauldsa and Duncan Graham*a
Dysfunctional intracellular enzymatic activity is believed to be an underlying cause of a myriad of diseases.
We present the ﬁrst use of surface enhanced Raman scattering (SERS) as a detection technique capable of
reporting intracellular activity of a speciﬁc enzyme. Careful choice of reagents allowed the preparation of
high resolution cellular activity maps highlighting the speciﬁc conversion of the commonly used ELISA
reagent 5-bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-Gal), by wild type b-galactosidase enzymes.
Further, through co-addition of X-Gal substrate and inhibitors we were able to demonstrate that
intracellular substrate conversion occurred predominantly through an enzymatically speciﬁc pathway.
The data presented therefore supports the application of SERS probes as sensitive, speciﬁc sensors of
biochemical activity and demonstrates the use of SERS probes for the ﬁrst time as beacons capable of
high resolution subcellular localisation of native enzymes.
Introduction
The functional integrity of individual cells and organisms is
crucially dependent upon the activity of cohorts of intracellular
enzymes. Dysfunctional activity, localisation or the absence of
specic enzymes is invariably associated with signicant
diseases including cystic brosis.1 As a result the ability to
measure the activity and localisation of specic enzymes within
a cellular environment is critical to life science research. A
variety of methods exist for this purpose however, most are
based on uorescence or colorimetric detection which are
limited in terms of either sensitivity or multiplexing capability.2
In addition, the reagents used for such analyses tend to provide
uniform coverage across the cell which is acceptable when
looking at populations but inadequate when trying to observe
the sub-cellular compartmentalisation of enzymatic activities.
Herein, we provide the rst description of the use of surface
enhanced Raman scattering (SERS) to detect galactosidase
enzymes within cells in a non-destructive manner. SERS was
facilitated by nanoparticle enhancement of the coloured
hydrolysis product generated from the colorimetric substrate, 5-
bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-Gal), a
commonly used marker for galactosidase enzymes.
SERS requires the detection of light inelastically scattered
from an analyte adsorbed onto a metal surface.3 Raman scat-
tering is an inherently weak process prone to interference from
uorescence however, the development of SERS has led to a
range of superior probes that show improved sensitivity and
which can quench uorescence.4,5 The main condition required
to obtain SERS is the adsorption of the analyte onto a suitable
enhancing surface, typically electrodes or specically designed
metal surfaces or nanoparticles.6 Gold or silver nanoparticles,
as used in the study, can be coupled with diﬀerent excitation
sources to match the plasmon frequency of either unaggregated
or aggregated nanoparticles.7 A further enhancement can also
be obtained by using an analyte which has an electronic tran-
sition coincident with the Raman excitation frequency.8
In our approach, b-galactosidase was studied as an intra-
cellular target to test the enzymatic generation of a SERS signal.
We have previously shown that conversion of typical ELISA dye
substrates, bromochloroindolylphosphate (BCIP) and 2,2-azino-
bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), can be
monitored by SERS in a sensitive and quantitative manner,
however, this was never extended into a biological environ-
ment.9,10 b-galactosidase enzymes are stable and have the ability
to hydrolyse dye substrates making them ideal for use in ELISAs
and for testing cell senescence.11 In vitro b-galactosidase levels
can currently be measured using the Miller technique12
however, this approach requires the destructive permeabilisa-
tion of the cell membrane. Herein, we report the rst use of
SERS to detect the activity of galactosidase enzymes from
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specic locations within cells by monitoring the conversion of
X-Gal.
Materials and methods
Materials
All materials purchased were from Sigma-Aldrich except b-
galactosidase (Calbiochem, UK) and gold nanoparticles, 40 nm
(British Biocell International, UK).
Measurements
Plate based spectroscopy was carried out using Renishaw inVia
Raman spectrometers using diﬀerent excitation wavelengths.
An Ar-ion laser was used for work using a 514.5 nm (7.30 mW)
incident wavelength, 632.8 nm (2.43mW) was provided by a He–
Ne laser and 785 nm utilised a laser diode (5.41 mW). An
Olympus 20 LWD objective (N.A. 0.4) was used and the spec-
trometer grating was centred at 600 cm1 and 10 s acquisitions
were used. The specic experiment being carried out dictated
what volumes of reagents were present in the sample wells.
SERS mapping was performed using Renishaw inVia Raman
spectrometers tted with inverted and upright microscope
systems equipped with a 100 LWD objective (N.A. 0.75) (6
mW power at the sample). Line mapping was performed using a
StreamLine Raman mapping system (Renishaw plc, UK).
SERS maps were coloured by integrating the area under the
characteristic peak at 598 cm1. A grating of 1200 l mm1 was
used with a RenCam CCD. Mapping was also performed with a
WiTec alpha 300R (100 objective, N.A. 0.95) confocal Raman
spectrometer (WiTec, Germany) (5 mW power at the sample).
Both utilised a He–Ne 632.8 nm laser. The Renishaw spec-
trometer grating was centred at 600 cm1 and used 10 s
acquisitions. TheWiTec system recorded spectra in the range 0–
3000 cm1 with 0.1 s acquisitions.
Sample preparation
Colloid. 50 mg of sodium tetrachloroaurate and 500 mL of
distilled water were added to a round-bottomed ask (which
had previously been cleaned using aqua regia) and heated until
boiling. A solution of 75 mg of sodium citrate in 7.5 mL distilled
water was added and the mixture was then allowed to boil for 15
min with continuous stirring. Aer cooling, the quality of the
colloid was conrmed using UV-Vis spectroscopy (lmax ¼ 521
nm) and transmission electron microscopy (TEM). The nano-
particle diameter was recorded for over one hundred of the gold
nanoparticles and the average value recorded was 19.66  2.65
nm.
X-Gal/inhibitor solutions. 5 mg of X-Gal was dissolved in 100
mL of dimethylformamide (DMF) before being added gradually
to phosphate buﬀered saline (PBS) to reach the required
concentrations. 5 mg of each inhibitor was also dissolved in
DMF before dilution to the desired concentrations in PBS. For in
vitro studies the solutions were diluted in Roswell Park
Memorial Institute (RPMI) media instead of PBS.
Cell preparation. Bone marrow macrophages were obtained
from Balb/C mice. Femurs were ushed with 5mL of Dulbecco's
Modied Eagle Media (DMEM) and the cells were cultured in a 9
cm Petri dish with 20% heat inactivated fetal calf serum (FCS),
30% cell culture supernatant from L929 cell line, 1% L-gluta-
mine (2 mM) and 1% penicillin/streptomycin solution (100 mg
mL1). On day 4 and 8 fresh media was added before harvesting
the cells on day 10. Cells were counted and plated out onto 13
mm cover slips in a 24 well tissue culture plate at 5  105 cells
per well in RPMI with 10% FCS, 1% L-glutamine and 1% peni-
cillin/streptomycin solution. To ensure the cells were xed to
the cover slips they were le overnight at 37 C, 5% CO2. Solu-
tions were prepared in RPMI (serum free) and were sterilized
before use in an appropriate tissue culture hood under UV light
for 30 min. The appropriate volumes and concentrations of
nanoparticles, X-Gal and inhibitor were made up to an overall
volume of 300 mL and were added to the cells to incubate for 24
h at 37 C, 5% CO2. Upon completion the media was removed
and the cells were washed twice with serum free RPMI. The cells
were xed with 1% glutaraldehyde for 15 min before washing
with PBS then rinsing with ddH2O. Cover slips were removed
from the plate and allowed to air dry for 2 h before mounting
onto a slide using DPX mountant.
Transmission electron microscopy (TEM). Cells were grown
to conuence on Thermanox (Agar Scientic, UK) coverslips
and incubated overnight with X-Gal (10 mM) and gold nano-
particles (0.1 nM). The cells were then washed (3) with PBS
before being xed for 2 h with 3% (v/v) glutaraldehyde in 0.1 M
sodium cacodylate buﬀer. Cells were washed a further 3 times
with sodium cacodylate buﬀer before a post-xation with 1% (v/
v) osmium tetroxide in 0.1 M sodium cacodylate buﬀer. Aer a
further wash the cells were dehydrated with acetone before
being inltrated and embedded in epoxy resin, allowing ultra-
thin sections to be taken by a diamond knife. Sections were
positioned on TEM grids and stained with 2% aqueous uranyl
acetate and the grids were examined and photographed at an
accelerating voltage of 80 keV in a CM120 Biotwin (Philips) TEM
with a digital camera.
Results and discussion
Prior to in vitro analysis the idealised SERS response was
investigated using nanoparticles and diﬀerent excitation
frequencies (514.5 nm, 632.8 nm and 785 nm) under buﬀer
conditions (10 mM phosphate buﬀer, pH 7.4). X-Gal itself yields
a minimal SERS signal however, the dimerised hydrolysis
product gives a strong peak at 598 cm1 due to a skeletal
vibration from the newly formed trans-alkene (Fig. 1 and S1,
S2†).13 A comparison between several diﬀerent, commonly used,
nanoparticle suspensions namely citrate reduced gold and
silver and EDTA reduced silver was carried out to compare the
surface enhancement achieved. The combination of 632.8 nm
excitation and gold nanoparticles (20 nm) provided the highest
SERS signal in the shortest time (Fig. S2†). Smaller particles are
inherently more stable and reliable and high signal intensity is
achieved since the X-Gal product produces a strong blue colour
with an absorbance maxima at 635 nm, putting it directly in
resonance with both the surface plasmon of the aggregated gold
nanoparticles (521 nm unaggregated, 630 nm aggregated) and
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the excitation frequency (632.8 nm). In order to prove that the
reaction could be aﬀected by known enzyme inhibitors two
commercially available competitive inhibitors of b-galactosi-
dase, phenylethyl-b-D-galactopyranoside (PEG) and phenylethyl-
b-D-thiolgalactopyranoside (PETG)14 were used to investigate the
inhibition of the enzyme and the resulting reduction of the
SERS signal. The X-Gal and nanoparticle concentrations were
maintained at 1 mM and 0.1 nM respectively. The inhibitor
concentration was varied from 10 mM to 0.1 mM and a dose
dependent response was observed (Fig. S3†). The inhibitors
themselves gave minimal Raman signal and therefore did not
inuence the signal obtained from the hydrolysis of the X-Gal.
A primary cell line, bone marrow-derived macrophages, was
chosen to study the measurement of b-galactosidase activity by
SERS. Macrophages naturally express b-galactosidase and readily
endocytose metallic nanoparticles therefore eliminating the issue
of cellular uptake of the nanoparticle substrates to obtain the
enhancement of the Raman scattering.15 Suspensions of nano-
particles (0.1 nM) and X-Gal with various concentrations (10–0.1
mM) were added to macrophage cells grown on cover slips.
Following 48 h of incubation the cells were washed, harvested and
the cover slips attached to slides. The Raman spectra obtained
from the cells are shown (Fig. 2A and B). The map is produced by
taking the signal to baseline area (570–620 cm1) of the major
peak centred at 598 cm1 at each individual pixel across the area.
The StreamLine mapping system on the Renishaw inVia system
utilizes line mapping, allowing large areas to be mapped rapidly
whilst minimising tissue damage. A typical map would be a
complete 150 micron by 100 micron area where Raman signals
were collected every 2 microns in the X co-ordinate and 1.1
microns in the Y co-ordinate. The streamline mapping approach
was limited to approximately 5–6 scans across the cell. Data can
also be observed from a larger population (120 cells) using a 20
objective as shown in Fig. 2C. The data presented is representative
of this type of experiment which has been repeatedmany times. It
was also possible to produce a dose dependant response from the
cells by varying the concentration of X-Gal substrate added to the
cells (10 mM to 0.1 mM) as shown in Fig. S4.†
In order to test the specicity of this enzymatic trans-
formation the two galactosidase inhibitors previously used in
the optimisation of the conditions were applied to the cells. If
the transformation was unique to the galactosidase then the
inhibitors would reduce the enzymatic activity resulting in a
lower SERS signal from the product of the X-Gal hydrolysis. In
this set of experiments the X-Gal and gold nanoparticle
concentrations were maintained at 10 mM and 0.1 nM respec-
tively and the inhibitor concentrations diluted from 10 mM to
0.1 mM. The results, as shown in Fig. 2D, clearly indicate that
there is a signicant diﬀerence in the response measured by
SERS when looking at the various concentrations of the two
diﬀerent inhibitors applied to the cells. In addition, it also
indicates that PEG appears to be more eﬀective than PETG 10 at
inhibiting the b-galactosidase and that this is a biomolecularly
specic interaction which is being measured using the gold
nanoparticles and SERS within the cells. The same false colour
scale was used throughout all maps.
TEM images taken of cell sections conrm that the nano-
particles were indeed inside the cell (Fig. 3A). The TEM images
indicate that the nanoparticles are contained within endosomes
and not simply adsorbed onto the cell membrane. Upon isola-
tion of the nanoparticle containing intracellular compartments
it was possible to characterise them as LAMP-1 expressing but
transferrin receptor negative suggesting these were late endo-
somes or lysosomes (Fig. S5†).16,17
In order to prepare higher denitionmaps to observe spectra
every 100 nm in the X and Y co-ordinates, a point mapping
approach was taken whereby the stage was moved by 400 mm2 in
combination with a 100 objective (N.A. 0.9) to provide
approximate lateral resolution of 461 nm optically. The results,
shown in Fig. 3B, are in agreement with the TEM image indi-
cating that sub-cellular localisation of the nanoparticles can be
observed by SERS. Furthermore, this is the rst demonstration
of the potential to measure enzyme activity at nanometre
dimensions using SERS. Also, as shown in Fig. 3C, it was
possible to screen a larger area of cells with the same high
resolution screening.
These results are the rst to demonstrate that SERS can be
used to detect enzyme activity in an intracellular environment
and that SERS provides several important advantages over
conventional approaches. Firstly, detection of the substrate X-
Gal with a commonly studied enzyme has been reported using
gold nanoparticles and SERS. The formation of a substrate
product which oﬀers a strong unique SERS ngerprint has been
monitored over a standard ELISA timeframe allowing the
observation of the increasing levels of enzyme turned-over
product. This aspect of the work is novel yet runs parallel to
some of our groups' earlier studies where we analysed the
suitability of SERS as a detection method with commonly used
ELISA reagents.9,10,18 Our results also show that the measure-
ment is specic to b-galactosidase enzymes since the addition
of b-galactosidase inhibitors reduces the observed SERS signal
and that the SERS response is dependent on inhibitor concen-
tration proving that we are not observing non-specic hydro-
lysis. The inhibitors used both contain a galactopyranoside
moiety and compete with X-Gal for the active site of the enzyme.
Fig. 1 SERS detection to monitor the conversion of X-Gal. The conversion of the
colourless X-Gal to the blue coloured (lmax ¼ 635 nm) 5,5
0-dibromo-4,40dichloro-
indigo by galactosidase (A) can be monitored by SERS. The product gives a new
sharp vibrational Raman peak at 598 cm1 as illustrated in the comparison of (B)
and (C).
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Turnover of X-Gal yields an indole/indigo dye with a large
vibrational Raman cross-section whereas the inhibitors produce
phenylethyl groups with negligible Raman responses.
By combining this chemical innovation with high resolution
SERS mapping it was possible to localise nanoparticles within
specic cellular sites and measure biomolecular activity.
Indeed, the ability to measure enzyme activity specically in the
endolysosome compartment allows the use of our approach in a
wide variety of biological systems and in particular is signicant
for major pathophysiological conditions associated with lyso-
somal enzyme disorders such as Parkinson's and Alzheim-
er's.16,17 Diﬀerential quantication of galactosidase enzyme
activities in these subcellular compartments during diﬀerent
disease states or inammatory processes will provide clear
insights as to how best to manipulate these biological systems
therapeutically. These studies strongly support the application
Fig. 2 Intracellular SERS detection. The bright ﬁeld (A) and false colour image (B) of three treated cells mapped by SERS using a 100 objective are shown. Spectra
associated with speciﬁc mapped pixels are shown below each ﬁgure and the scale bar in (A) and (B) represents 20 mm. A false colour scale bar was used throughout and
this is also shown below (A) and (B). Areas with no Raman signal appear black and areas with increasing peak intensity at 598 cm1 are represented by increasing
brightness. (C) Uses the same technique but looks at a larger areawith use of a 20 objective. (D) Demonstrates the eﬀect of inhibitor concentration on the cellular SERS
response for both phenylethyl-b-D-galactopyranoside (PEG) and phenylethyl-b-D-thiolgalactopyranoside (PETG). The X-Gal and nanoparticle concentrations were 10
mM and 0.1 mM respectively.
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of SERS approaches to quantify and localise specic multipa-
rameter biochemical activities within cells which will have a
signicant impact on functional biochemical imaging and
analysis of a variety of biological samples.
Conclusions
The application of nanoparticles to cells has been a eld of
intense research and here we show that by combining the
innovative detection of the X-Gal product with high resolution
SERS mapping it becomes possible to localise the nanoparticles
to specic cellular sites. It should be noted that SERS has
previously been used in intracellular studies to measure pH and
to detect 11 individual cellular components.19–22 However, these
earlier studies have either delivered SERS active nanoparticles
into cells22 or have relied on the cellular components to oﬀer
modest Raman gains.21 In this particular study metallic nano-
particles were employed to selectively enhance the molecular
vibrations of a molecule which only becomes Raman active
upon interaction with the target enzyme and this is the rst
documented intracellular Raman enzyme detection method. It
is worth raising the point that we only observe signals from
specic areas within the cell where both the nanoparticles and
the turned-over product are present. However, this may not
represent the true location of the enzymes. Further, it is
possible that an area with a high Raman signal could be
indicative of either a high concentration of nanoparticles or
high enzyme concentration as it is well established that aggre-
gated nanoparticles yield greater SERS signal. Although uo-
rescence spectroscopy has traditionally been the technique of
choice for the monitoring of such enzyme activity it is clear that
the SERS method confers numerous advantages over uores-
cence namely the ability to obtain specic molecular informa-
tion and its multiplexing capability. Indeed the potential to
detect and measure the activity and location of multiple
enzymes exists as a direct result of the sharp molecularly
specic spectral bands produced by SERS. In addition, it is
hoped that with the introduction of live cells, ultrafast Raman
imaging, careful temporal analysis and complementary TEM
analysis SERS approaches may be able to denitively ascribe
enzymes to specic cellular locations. These studies strongly
support the application of SERS approaches to quantify and
Fig. 3 Localisation of nanoparticles within cells. Macrophages treated with gold nanoparticles are show in (A). A magniﬁed version of the highlighted area is shown in
the lower ﬁgure. (B) High resolution mapping of two individual macrophage cells and their associated false colour Raman images. (C) High resolution mapping of a cell
population using a 20 objective.
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localise specicmultiparameter biochemical activities within cells.
This will have a signicant impact on functional biochemical
imaging and the analysis of a variety of biological samples.
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